Funded by the NIH HEAL Initiative®
This study will include analyses of VA databases to examine patient and organizational characteristics associated with buprenorphine termination during outpatient treatment for opioid use disorder. These analyses are critical for generating data and forming further hypotheses on how to implement targeted approaches to improve retention in treatment.
Adam J. Gordon, MD, MPH, FACP, DFASAM, CMRO
Professor of Medicine and Psychiatry
University of Utah Health
383 Colorow Way, Mailbox 16, Salt Lake City, UT, 84108, US
CTN-0087 completed